Medtronic plc (MDTC34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 19 Oct 2026
Key indicators
| Last close | BRL 59.10 |
|---|---|
| 52-week range | 44.77 – 65.10 |
| Return, 1 month / 3 months | −1.0% / +14.2% |
| Return, 1 year / 3 years | −3.3% / +60.5% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 29.1% |
| Worst drawdown (1 year) | -31.2% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 27.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Medtronic plc is a medical technology company that develops and makes devices and therapies for patients with chronic conditions. Its products include heart devices such as pacemakers and defibrillators, insulin pumps, spinal and surgical equipment, and tools used in minimally invasive procedures. Customers are mainly hospitals, clinics and physicians who use these products to treat cardiac, neurological, diabetes and other conditions. The company is headquartered in Ireland and operates across markets worldwide.
Medtronic plc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code MDTC34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Medtronic plc (MDTC34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 59.10 on 19 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 427 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.3% and over the last three months it rose 14.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.9% | ||
| From 52-week high | -9.2% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 14.2% | ||
| 6-month return | 10.5% | ||
| 12-month return, skipping the last month | -2.3% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.2% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 28.3% | ||
| Income | 83 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 27.0% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +7.5% |
|---|---|
| 1 month | −1.0% |
| 3 months | +14.2% |
| 6 months | +10.5% |
| 1 year | −3.3% |
| 3 years | +60.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 58.49 / 55.78 |
|---|---|
| Golden / death cross (60 days) | Golden, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jun 2026 | EUR 5.3108 |
| 25 Mar 2026 | EUR 5.1290 |
| 22 Dec 2025 | EUR 5.5350 |
| 24 Sep 2025 | EUR 5.5410 |
| 25 Jun 2025 | EUR 5.7208 |
| 26 Mar 2025 | EUR 5.9274 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.